Kura Oncology (KURA) insider trading in the last 6 months

One insider bought $2.4M, 4 sold $1.1M.

Quality Score-7Poor

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 9 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellMollie Leoni$310KChief Medical Officerat $10.75 on Sep 29, filed Sep 29

SellMollie LeoniChief Medical Officer$310Kat $10.75 on Sep 29, filed Sep 29

SellBrian T. Powl$166KChief Commercial Officerat $10.75 on Sep 29, filed Sep 29

SellBrian T. PowlChief Commercial Officer$166Kat $10.75 on Sep 29, filed Sep 29

SellMollie Leoni$131KChief Medical Officerat $10.50 on Sep 28, filed Sep 29

SellMollie LeoniChief Medical Officer$131Kat $10.50 on Sep 28, filed Sep 29

From SEC Form 4s, the newest filed Sep 29, 2026 · Insiders have 2 business days to file a trade

6 more filings on KURA in the last 6 months, for Pro members. See them free →

Pro members see every filing on KURA with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Kura Oncology

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about KURA's insider trades

As of Nov 10, 2026: Kura Oncology (KURA) has 9 insider filings on record in the last 6 months, the newest filed Sep 29, 2026. Its Quality Score is -7 (Poor). Scores as of 11:35 PM ET, 15 minutes behind.

Are KURA insiders buying or selling?

One insider bought $2.4M across 2 filings, and 4 insiders sold $1.1M across 7 filings, in the last 6 months. The newest filing: Mollie Leoni, Chief Medical Officer, sold $310K on Sep 29, 2026.

Who are KURA's biggest insider sellers?

By the dollars of their sales in the last 6 months: Mollie Leoni (Chief Medical Officer), 2 sales; Brian T. Powl (Chief Commercial Officer), 3 sales; Francis Burrows (Chief Scientific Officer), 1 sale. 4 insiders sold in all.

When did a KURA insider last buy?

Troy Edward Wilson, President and CEO, bought KURA shares on Aug 24, 2026, the newest insider buy on record.

Kura Oncology's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. KURA is on insider buys, Aug 24 to 30, 2026.

Kura Oncology (KURA) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Kura Oncology

Questions about KURA's insider trades

Every insider trade, with its stock's score.